Maverix Biomics
Stage
Series A | AliveTotal Raised
$6MLast Raised
$6M | 9 yrs agoRevenue
$0000About Maverix Biomics
Maverix Biomics provides research scientists with an open, cloud-based platform integrating best-in-class open-source software that anticipates user needs, enables communities of discovery, and integrates data in context with the latest biomic information for viral, bacterial, vertebrate, and plant genomes.
Missing: Maverix Biomics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Maverix Biomics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Maverix Biomics News
Dec 8, 2015
a GenomeWeb staff reporter NEW YORK (GenomeWeb) — Maverix Biomics and Diagnomics announced today that they have received CLIA validation for their next-generation sequencing pre-natal test on the Maverix Dx platform. The test, called Non-Invasive Chromosome Examination (NICE), was developed by Diagnomics and the Eone-Diagnomics Genome Center, a joint venture between Diagnomics and the Eone Life Science Institute. It uses NGS to detect fetal chromosome aneuploidies in cell-free DNA, the companies said in a statement. Get the full story
Maverix Biomics Frequently Asked Questions (FAQ)
Where is Maverix Biomics's headquarters?
Maverix Biomics's headquarters is located at 1670 S Amphlett Blvd, San Mateo.
What is Maverix Biomics's latest funding round?
Maverix Biomics's latest funding round is Series A.
How much did Maverix Biomics raise?
Maverix Biomics raised a total of $6M.
Who are the investors of Maverix Biomics?
Investors of Maverix Biomics include Asset Management Ventures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.